EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metallothionein 1B attenuates inflammation and hepatic steatosis in MASH by inhibiting the AKT/PI3K pathway

Canghai Guan, Xinlei Zou, Wujiang Shi, Jianjun Gao, Chengru Yang, Yifei Ge, Zhaoqiang Xu, Shaowu Bi, Xiangyu Zhong

Journal of Lipid Research · 2025

DOI: 10.1016/j.jlr.2024.100701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Canghai Guan und 8 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery Department, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myo…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Metallothionein, Phosphatidylinositol 3-Kinases, Inflammation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilongjiang Provincial Postdoctoral Science Foundation, Heilongjiang Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatohepatitis (MASH) is a severe form of metabolic dysfunction-associated fatty liver disease metabolic dysfunction-associated steatohepatitis , characterized by hepatic steatosis, inflammation, and fibrosis. This study investigates the role and potential mechanisms of metallothionein 1B (MT1B) in MASH through bioinformatics analysis and experimental validation. quantitative reverse transcription PCR and Western blot analyses confirm that MT1B expression is significantly downregulated in liver tissues of MASH patients, in high-fat diet-induced mouse models, and in hepatocytes induced by FFAs. Further functional experiments show that upregulation of MT1B reduces intracellular triglycerides and total cholesterol levels, lipid droplet formation, and proinflammatory factors. In vivo experiments demonstrate that specific downregulation of hepatic MT1B expression via AAV8-shMT1B injection significantly increases triglyceride and total cholesterol levels, exacerbates lipid accumulation, and markedly elevates liver fibrosis and inflammatory factor expression. RNA-seq and bioinformatics analyses show that the AKT/PI3K pathway is significantly suppressed in MT1B-overexpressing cells. Further experiments indicate that AKT inhibition can reverse the lipid metabolism disorders and inflammatory responses caused by MT1B downregulation. Additionally, Zinc can promote the nuclear translocation of MTF1, leading to its binding to the MT1B promoter, thereby upregulating MT1B expression and ultimately mitigating MASH progression. These findings suggest that zinc-regulated MT1B plays a critical role in lipid metabolism and inflammatory responses by regulating the AKT/PI3K signaling pathway, influencing MASH progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktMetallothioneinPhosphatidylinositol 3-KinasesInflammationFatty LiverAnimalsMiceHumansMaleSignal TransductionMice, Inbred C57BL

Stichwörter der Autor:innen

AKT/PI3KMT1BMTF1associated steatohepatitismetabolic dysfunctionzinc

Substanzen

Proto-Oncogene Proteins c-aktMetallothioneinPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • General Surgery Department, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Ha…
  • General Surgery Department, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.
  • General Surgery Department, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China. Electronic address: hmuzhongxy@163.com.

Förderung

  • Heilongjiang Provincial Postdoctoral Science Foundation
  • Heilongjiang Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Guan, C., Zou, X., Shi, W., Gao, J., Yang, C., Ge, Y., Xu, Z., Bi, S., & Zhong, X. (2025). Metallothionein 1B attenuates inflammation and hepatic steatosis in MASH by inhibiting the AKT/PI3K pathway. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2024.100701

Vancouver

Guan C, Zou X, Shi W, Gao J, Yang C, Ge Y, et al. Metallothionein 1B attenuates inflammation and hepatic steatosis in MASH by inhibiting the AKT/PI3K pathway. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2024.100701

BibTeX
@article{Guan2025,
  author = {Guan, Canghai and Zou, Xinlei and Shi, Wujiang and Gao, Jianjun and Yang, Chengru and Ge, Yifei and Xu, Zhaoqiang and Bi, Shaowu and Zhong, Xiangyu},
  title = {Metallothionein 1B attenuates inflammation and hepatic steatosis in MASH by inhibiting the AKT/PI3K pathway},
  journal = {Journal of Lipid Research},
  year = {2025},
  doi = {10.1016/j.jlr.2024.100701}
}
Kostenlos starten →